PAVmed Inc. logo

PAVmed Inc.

PAVM | NASDAQ
Chart Builder DCF Calculator
$3.97
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$3.95
-$0.02 (-0.50%)
After-hours: Sep 21, 2026, 4:38 PM ET

Market Data

Market Cap
$25.28M
Enterprise Value
$38.62M
Beta
0.54
Average Volume
24.3K
Shares Outstanding (Diluted)
6.27M
Shares Change YoY
940.01%
Institutional Ownership
32.39%
Exchange
NASDAQ
ISIN
US70387R5028

Price Performance

Price Change 1M
-22.2%
Price Change 3M
-15.2%
Price Change 6M
-57.3%
Price Change YTD
-45.8%
Price Change 1Y
-70.4%
Price Change 3Y
-97.2%
Price Change 5Y
-99.9%
1M CAGR (ann.)
-19.8%
1Y CAGR (ann.)
-67.3%
5Y CAGR (ann.)
-74.5%
All-Time CAGR
-46.5%

Valuation

PE Ratio
-0.24
Forward PE
N/A
PEG Ratio
0.00
Forward PEG
0.01
PS Ratio
0.77
Forward PS
42.20
PB Ratio
0.72
P/FCF Ratio
-0.01
P/Adj. FCF Ratio
-0.01
P/OCF Ratio
-0.01
EV/Sales
1.17
EV/EBIT
-3.93
EV/EBITDA
-0.01
EV/FCF
-0.01
Earnings Yield
-412.1%
FCF Yield
-10359.3%
Adj. FCF Yield
-11083.6%

Financial Health

Net Debt
$11.32M
Total Debt
$17.07M
Cash & Short-Term Investments
$3.78M
Total Assets
$40.21M
Current Ratio
1.19
Quick Ratio
1.19
Debt / Equity Ratio
0.49
Debt / EBITDA
-0.00
Debt / FCF
-0.01
OCF / Debt
-153.80
Interest Coverage
-1,483.56
Altman Z-Score
-8.44
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
-254.5%
Operating Profit Margin
-21287.5%
EBITDA Margin
-14600.0%
Net Profit Margin
-10794.6%
FCF Margin
-7936.0%
Adj. FCF Margin
-8490.8%
SBC / Revenue
163867.9%
SBC Impact (per share)
-7.0%

Returns

Return on Assets
-30.1%
Return on Equity
-33.5%
Return on Invested Capital
-72.8%
Return on Capital Employed
-73.9%
Return on Tangible Assets
-30.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
245.8%
Revenue CAGR 5Y
82.5%
Revenue CAGR 10Y
50.3%
EPS CAGR 3Y
151.3%
EPS CAGR 5Y
57.9%
EPS CAGR 10Y
13.1%
FCF CAGR 3Y
-144.0%
FCF CAGR 5Y
-90.2%
FCF CAGR 10Y
-50.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
1
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$0.63
EPS Growth Est (next Q)
-92.8%
Revenue Est (next Q)
$25K
Revenue Growth Est (next Q)
400.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$57
Price Target Upside
1335.8%

Cash Flow

Operating Cash Flow
$-2.63B
Free Cash Flow
$-2.63B
Adj. Free Cash Flow
$-2.81B
FCF Per Share
-$418.72
OCF Per Share
-$418.72
OCF/S Ratio
-2343848.2%

Income Statement

Revenue
$33.08M
Gross Profit
$-89.2M
Operating Income
$-7.04B
EBITDA
$-7.03B
Net Income
$-5.49B
EPS (Diluted)
-$16.36
Revenue / Employee
$806.8K
Profit / Employee
$-133.8M
Employees
41

© 2026 bestshares.com. All rights reserved.